1 The retractions came only a few months after BioMed Central ed medicine.

Charlotte J. Haug, M.D ed medicine ., Ph.D.1 The retractions came only a few months after BioMed Central, an open-access publisher owned by Springer, retracted 43 content articles for the same reason. How can you really fake peer review? Moon, who studies medicinal plants, had set up a straightforward process. He gave journals tips for peer reviewers for his manuscripts, providing them with e-mail and brands addresses. But these addresses had been ones he created, therefore the requests to review went right to him or his co-workers. The fallout from Moon’s confession: 28 content articles in various journals published by Informa were retracted, and one editor resigned. An editor at among the journals published by Sage Publications became suspicious, sparking a thorough and lengthy investigation, which resulted in the retraction of 60 articles in July 2014.

Patients with unprovoked venous thromboembolism are in risky for recurrence after oral anticoagulant treatment is withdrawn.3-6 Extending anticoagulant therapy reduces the chance of recurrence but just as long as the procedure is continued.3,5,16 In clinical practice, anticoagulant therapy is normally discontinued when the perceived risk of bleeding or the inconvenience of continuing anticoagulant treatment outweighs the chance of recurrence. Our research demonstrates aspirin therapy is definitely a potential option to prolonged oral anticoagulant treatment for the long-term secondary avoidance of venous thromboembolism.